EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

Autologous endothelial progenitor cells for the treatment of critical limb ischemia

The aim of this trial was to asses the safety and efficacy of immunoselected autologous CD133+  endothelial progenitor cells in the treatment of critical limb ischemia.
See additional Cell Therapies for: Endothelium
Autologous endothelial progenitor cells for the treatment of critical limb ischemia
Home
Contact Us
About Terms of Use Privacy Policy
Copyright LifeMap Sciences, Inc. - All Rights Reserved (v4.14 Build 1)
This site does not provide medical advice and is for research use only